Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction - PubMed (original) (raw)
Randomized Controlled Trial
. 2008 Aug 18;128(2):185-92.
doi: 10.1016/j.ijcard.2007.04.098. Epub 2007 Aug 30.
Stanislav Janousek, Jirí Mayer, Ladislav Groch, Ivan Hornácek, Ota Hlinomaz, Petr Kala, Roman Panovský, Jirí Prásek, Milan Kamínek, Jaroslav Stanícek, Martin Klabusay, Zdenek Korístek, Milan Navrátil, Ladislav Dusek, Jaroslava Vinklárková
Affiliations
- PMID: 17764767
- DOI: 10.1016/j.ijcard.2007.04.098
Randomized Controlled Trial
Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction
Jaroslav Meluzín et al. Int J Cardiol. 2008.
Abstract
Background: There are only few data on long-term effectiveness of the stem cell therapy.
Aim: We studied the time course of global and regional left ventricular function in patients with acute myocardial infarction within 1 year after the autologous mononuclear bone marrow cell transplantation.
Methods: Sixty patients with a first acute myocardial infarction, who had been randomized into 3 groups, completed a 12-month protocol. Two groups were intracoronarily given bone marrow cells in either higher (10(8) cells, HD group, n=20) or lower (10(7) cells, LD group, n=20) doses. Twenty patients without cell transplantation served as a control (C) group. Doppler tissue imaging and the gated technetium-99m sestamibi single photon emission computed tomography were performed before cell transplantation and at 3, 6, and 12 months later.
Results: The baseline peak systolic velocities of longitudinal contraction of the infarcted wall (S(infarct)) of 5.2 cm/s, 4.6 cm/s, and 4.4 cm/s in C, LD, and HD groups increased by 0.0 cm/s, 0.3 cm/s (p=NS vs. C group), and by 0.7 cm/s (p<0.05 vs. C group), respectively, at 3 months. At 12 months, however, the corresponding changes from baseline values of 0.1 cm/s, 0.2 cm/s, and 0.6 cm/s did not differ significantly (all p=NS). In contrast, the post-transplant improvements in the left ventricular ejection fraction by 6%, 7%, and 7% at months 3, 6, and 12, respectively, were preserved in HD group patients during the whole 12-month follow-up and remained significantly better as compared to controls.
Conclusions: In our study, the autologous mononuclear bone marrow cell transplantation provided sustained improvement in global left ventricular systolic function in patients with acute myocardial infarction. However, when evaluating regional systolic function of the infarcted wall, the short-term benefit was partially lost during the 12-month follow-up.
Similar articles
- Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function.
Meluzín J, Mayer J, Groch L, Janousek S, Hornácek I, Hlinomaz O, Kala P, Panovský R, Prásek J, Kamínek M, Stanícek J, Klabusay M, Korístek Z, Navrátil M, Dusek L, Vinklárková J. Meluzín J, et al. Am Heart J. 2006 Nov;152(5):975.e9-15. doi: 10.1016/j.ahj.2006.08.004. Am Heart J. 2006. PMID: 17070173 Clinical Trial. - Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction.
Chen SL, Fang WW, Qian J, Ye F, Liu YH, Shan SJ, Zhang JJ, Lin S, Liao LM, Zhao RC. Chen SL, et al. Chin Med J (Engl). 2004 Oct;117(10):1443-8. Chin Med J (Engl). 2004. PMID: 15498362 Clinical Trial. - Randomized controlled trials on the therapeutic effects of adult progenitor cells for myocardial infarction: meta-analysis.
Jiang M, He B, Zhang Q, Ge H, Zang MH, Han ZH, Liu JP, Li JH, Zhang Q, Li HB, Jin Y, He Q, Gong XR, Yin XY. Jiang M, et al. Expert Opin Biol Ther. 2010 May;10(5):667-80. doi: 10.1517/14712591003716437. Expert Opin Biol Ther. 2010. PMID: 20384520 Review. - Autologous bone marrow stem cell transplantation in acute myocardial infarction-report of two cases.
Siminiak T, Grygielska B, Jerzykowska O, Fiszer D, Kałmucki P, Rzeźniczak J, Kurpisz M. Siminiak T, et al. Kardiol Pol. 2003 Dec;59(12):502-10. Kardiol Pol. 2003. PMID: 14724697 Review.
Cited by
- The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders.
Borlongan CV, Glover LE, Tajiri N, Kaneko Y, Freeman TB. Borlongan CV, et al. Prog Neurobiol. 2011 Oct;95(2):213-28. doi: 10.1016/j.pneurobio.2011.08.005. Epub 2011 Aug 30. Prog Neurobiol. 2011. PMID: 21903148 Free PMC article. Review. - Stem cell transplantation dose in patients with acute myocardial infarction: A meta-analysis.
Xu JY, Cai WY, Tian M, Liu D, Huang RC. Xu JY, et al. Chronic Dis Transl Med. 2016 Nov 9;2(2):92-101. doi: 10.1016/j.cdtm.2016.09.006. eCollection 2016 Jun. Chronic Dis Transl Med. 2016. PMID: 29063029 Free PMC article. - Clinical efficacy and safety of autologous stem cell transplantation for patients with ST-segment elevation myocardial infarction.
Li R, Li XM, Chen JR. Li R, et al. Ther Clin Risk Manag. 2016 Aug 1;12:1171-89. doi: 10.2147/TCRM.S107199. eCollection 2016. Ther Clin Risk Manag. 2016. PMID: 27536122 Free PMC article. - Cell tracking in cardiac repair: what to image and how to image.
Ruggiero A, Thorek DL, Guenoun J, Krestin GP, Bernsen MR. Ruggiero A, et al. Eur Radiol. 2012 Jan;22(1):189-204. doi: 10.1007/s00330-011-2190-7. Epub 2011 Jul 7. Eur Radiol. 2012. PMID: 21735069 Free PMC article. Review. - Enhanced penetration of exogenous EPCs into brains of APP/PS1 transgenic mice.
Yuan X, Mei B, Zhang L, Zhang C, Zheng M, Liang H, Wang W, Zheng J, Ding L, Zheng K. Yuan X, et al. Am J Transl Res. 2016 Mar 15;8(3):1460-70. eCollection 2016. Am J Transl Res. 2016. PMID: 27186272 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous